Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00264485Phase 3Completed
Phase 3, randomised, open-label trial of fentanyl in postoperative pain (2 arms), sponsored by ALZA Corporation. Primary endpoint: Success on 24-hour Patient Global Assessment of the Method of Pain Control. Started Mar 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00264485.